(1->4)-beta-D-glucan multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATP6V0D2 mRNA CTD PMID:36331819 1,1-dichloroethene decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of ATP6V0D2 mRNA CTD PMID:26682919 1,4-dioxane decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 1 and 4-dioxane results in decreased expression of ATP6V0D2 mRNA CTD PMID:33693819 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of ATP6V0D2 mRNA CTD PMID:30723492 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Atp6v0d2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ATP6V0D2 mRNA CTD PMID:26377647 and PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP6V0D2 mRNA CTD PMID:26290441 and PMID:29673856 2-aminopurine multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 2-Aminopurine inhibits the reaction [[TNF protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 protein] CTD PMID:25739386 3,3',5,5'-tetrabromobisphenol A increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 tetrabromobisphenol A results in increased expression of ATP6V0D2 mRNA CTD PMID:33476716 3,4-dichloroaniline increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 3 and 4-dichloroaniline results in increased expression of ATP6V0D2 mRNA CTD PMID:24172598 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ATP6V0D2 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO ATP6V0D2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of ATP6V0D2 intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO ATP6V0D2 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of ATP6V0D2 intron CTD PMID:30157460 Aroclor 1254 decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ATP6V0D2 mRNA CTD PMID:23650126 avobenzone increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 avobenzone results in increased expression of ATP6V0D2 mRNA CTD PMID:31016361 benzo[a]pyrene decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of ATP6V0D2 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO ATP6V0D2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of ATP6V0D2 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO ATP6V0D2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of ATP6V0D2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO Atp6v0d2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ATP6V0D2 mRNA CTD PMID:22228805 and PMID:32417428 benzo[e]pyrene increases methylation ISO ATP6V0D2 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of ATP6V0D2 intron CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP6V0D2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 bisphenol A results in decreased expression of ATP6V0D2 mRNA CTD PMID:32156529 bisphenol A increases expression ISO Atp6v0d2 (Mus musculus) 6480464 bisphenol A results in increased expression of ATP6V0D2 mRNA and bisphenol A results in increased expression of ATP6V0D2 protein CTD PMID:35479511 bisphenol A affects expression ISO ATP6V0D2 (Homo sapiens) 6480464 bisphenol A affects the expression of ATP6V0D2 mRNA CTD PMID:30903817 bisphenol F decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 bisphenol F results in decreased expression of ATP6V0D2 mRNA CTD PMID:35387338 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of ATP6V0D2 mRNA CTD PMID:32479839 cadmium atom multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D2 mRNA CTD PMID:37325564 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of ATP6V0D2 promoter CTD PMID:22457795 cadmium dichloride multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D2 mRNA CTD PMID:37325564 carbon nanotube increases expression ISO Atp6v0d2 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of ATP6V0D2 mRNA CTD PMID:25554681 carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon results in increased expression of ATP6V0D2 mRNA CTD PMID:24911292 carbon nanotube affects expression ISO Atp6v0d2 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of ATP6V0D2 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 choline multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP6V0D2 mRNA CTD PMID:20938992 cis-caffeic acid multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 caffeic acid promotes the reaction [Thapsigargin results in decreased expression of ATP6V0D2 mRNA] CTD PMID:19442820 cisplatin multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ATP6V0D2 mRNA CTD PMID:27392435 cisplatin increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 Cisplatin results in increased expression of ATP6V0D2 mRNA CTD PMID:27392435 clothianidin increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 clothianidin results in increased expression of ATP6V0D2 mRNA CTD PMID:31626844 copper atom multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of ATP6V0D2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of ATP6V0D2 mRNA CTD PMID:20971185 cyclosporin A increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of ATP6V0D2 mRNA CTD PMID:25562108 and PMID:27989131 desferrioxamine B multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 Deferoxamine affects the reaction [TF protein affects the expression of ATP6V0D2 mRNA] and TF protein affects the reaction [Deferoxamine affects the expression of ATP6V0D2 mRNA] CTD PMID:31238089 desferrioxamine B affects expression ISO Atp6v0d2 (Mus musculus) 6480464 Deferoxamine affects the expression of ATP6V0D2 mRNA CTD PMID:31238089 dextran sulfate multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0D2 mRNA CTD PMID:29950665 dimethyl fumarate multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 Dimethyl Fumarate inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mRNA] CTD PMID:30742845 dioxygen multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of ATP6V0D2 mRNA CTD PMID:30529165 diuron increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 Diuron metabolite results in increased expression of ATP6V0D2 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of ATP6V0D2 mRNA CTD PMID:29391264 fenamidone increases expression ISO Atp6v0d2 (Mus musculus) 6480464 fenamidone results in increased expression of ATP6V0D2 mRNA CTD PMID:27029645 folic acid multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP6V0D2 mRNA CTD PMID:20938992 furan increases expression ISO Atp6v0d2 (Mus musculus) 6480464 furan results in increased expression of ATP6V0D2 mRNA CTD PMID:24183702 furan increases expression EXP 6480464 furan results in increased expression of ATP6V0D2 mRNA CTD PMID:27387713 furan decreases expression EXP 6480464 furan results in decreased expression of ATP6V0D2 mRNA CTD PMID:25539665 GW 4064 decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 GW 4064 results in decreased expression of ATP6V0D2 mRNA CTD PMID:26655953 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ATP6V0D2 mRNA CTD PMID:22129741 L-methionine multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP6V0D2 mRNA CTD PMID:20938992 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of ATP6V0D2 mRNA CTD PMID:35283115 lipopolysaccharide multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ATP6V0D2 mRNA CTD PMID:35811015 mangiferin multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ATP6V0D2 mRNA] CTD PMID:20683903 metformin decreases expression EXP 6480464 Metformin results in decreased expression of ATP6V0D2 mRNA CTD PMID:31324951 methapyrilene increases methylation ISO ATP6V0D2 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of ATP6V0D2 intron CTD PMID:30157460 methotrexate affects expression ISO Atp6v0d2 (Mus musculus) 6480464 Methotrexate affects the expression of ATP6V0D2 mRNA CTD PMID:18502557 methylmercury chloride increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of ATP6V0D2 mRNA CTD PMID:28001369 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ATP6V0D2 mRNA CTD PMID:22129741 N-acetyl-L-cysteine multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of ATP6V0D2 mRNA more ... CTD PMID:30742845 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ATP6V0D2 mRNA CTD PMID:22129741 naringin multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of ATP6V0D2 mRNA] CTD PMID:21835177 niclosamide multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of ATP6V0D2 mRNA] CTD PMID:26792726 ozone multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATP6V0D2 mRNA more ... CTD PMID:25658374 more ... panobinostat increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 panobinostat results in increased expression of ATP6V0D2 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0D2 mRNA CTD PMID:27188386 perfluorooctane-1-sulfonic acid multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATP6V0D2 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ATP6V0D2 mRNA CTD PMID:36331819 permethrin decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 Permethrin results in decreased expression of ATP6V0D2 mRNA CTD PMID:30629241 phenobarbital multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ATP6V0D2 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO Atp6v0d2 (Mus musculus) 6480464 Phenobarbital results in increased expression of ATP6V0D2 mRNA CTD PMID:19482888 pravastatin increases expression EXP 6480464 Pravastatin results in increased expression of ATP6V0D2 mRNA CTD PMID:27225895 pravastatin decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 Pravastatin results in decreased expression of ATP6V0D2 mRNA CTD PMID:27225895 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ATP6V0D2 mRNA CTD PMID:35811015 SB 203580 multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [SB 203580 co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of ATP6V0D2 mRNA more ... CTD PMID:30742845 SB 431542 multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sclareol decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 sclareol results in decreased expression of ATP6V0D2 mRNA CTD PMID:33423118 sclareol multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 sclareol inhibits the reaction [TNFSF11 protein results in increased expression of ATP6V0D2 mRNA] CTD PMID:33423118 silicon dioxide increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of ATP6V0D2 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO Atp6v0d2 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of ATP6V0D2 mRNA CTD PMID:29203145 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of ATP6V0D2 mRNA CTD PMID:22431001 and PMID:32721576 silicon dioxide decreases expression ISO ATP6V0D2 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of ATP6V0D2 mRNA CTD PMID:23806026 sodium arsenite multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of ATP6V0D2 mRNA] more ... CTD PMID:30742845 sotorasib multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ATP6V0D2 mRNA CTD PMID:36139627 styrene increases expression EXP 6480464 Styrene results in increased expression of ATP6V0D2 mRNA CTD PMID:17654243 succimer multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ATP6V0D2 mRNA CTD PMID:21641980 sulforaphane multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of ATP6V0D2 mRNA CTD PMID:30529165 sulforaphane decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 sulforaphane results in decreased expression of ATP6V0D2 mRNA CTD PMID:30529165 tamoxifen decreases expression ISO Atp6v0d2 (Mus musculus) 6480464 Tamoxifen results in decreased expression of ATP6V0D2 mRNA CTD PMID:25123088 Testosterone propionate increases expression ISO Atp6v0d2 (Mus musculus) 6480464 Testosterone Propionate results in increased expression of ATP6V0D2 mRNA CTD PMID:15601916 tetrachloroethene increases expression ISO Atp6v0d2 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of ATP6V0D2 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO Atp6v0d2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of ATP6V0D2 mRNA CTD PMID:27339419 and PMID:29987408 thapsigargin multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in decreased expression of ATP6V0D2 mRNA] and caffeic acid promotes the reaction [Thapsigargin results in decreased expression of ATP6V0D2 mRNA] CTD PMID:19442820 thapsigargin decreases expression ISO ATP6V0D2 (Homo sapiens) 6480464 Thapsigargin results in decreased expression of ATP6V0D2 mRNA CTD PMID:19442820 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ATP6V0D2 mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of ATP6V0D2 mRNA CTD PMID:30012374 titanium dioxide multiple interactions ISO Atp6v0d2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0D2 mRNA CTD PMID:29950665 trametinib multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ATP6V0D2 mRNA CTD PMID:36139627 trans-caffeic acid multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 caffeic acid promotes the reaction [Thapsigargin results in decreased expression of ATP6V0D2 mRNA] CTD PMID:19442820 tremolite asbestos increases expression ISO Atp6v0d2 (Mus musculus) 6480464 tremolite results in increased expression of ATP6V0D2 mRNA CTD PMID:29279043 trichostatin A increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 trichostatin A results in increased expression of ATP6V0D2 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0D2 mRNA CTD PMID:27188386 urethane increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 Urethane results in increased expression of ATP6V0D2 mRNA CTD PMID:28818685 valproic acid affects expression ISO ATP6V0D2 (Homo sapiens) 6480464 Valproic Acid affects the expression of ATP6V0D2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO ATP6V0D2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0D2 mRNA CTD PMID:27188386 valproic acid increases expression ISO ATP6V0D2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ATP6V0D2 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO ATP6V0D2 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of ATP6V0D2 gene CTD PMID:29154799 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of ATP6V0D2 mRNA CTD PMID:27225895 zaragozic acid A affects expression ISO Atp6v0d2 (Mus musculus) 6480464 squalestatin 1 affects the expression of ATP6V0D2 mRNA CTD PMID:27225895
